Renal stone analysis: why and how?
Upper urinary tract stone disease is widespread in the developed world. On both clinical and economic grounds it is now accepted that evidence-based medical intervention is the only approach likely to make a significant impact on the incidence, and more importantly, the recurrence rates of this disease. Targeted medical prophylaxis requires reliable information on stone type which, when combined with relevant blood and urine analyses, allows identification of treatable risk factors. Data from an external quality assurance scheme indicate that stone analysis is poorly performed in many laboratories, and it is probable that this results in ill-informed patterns of investigation, inappropriate therapy, missed diagnoses of rarer causative disorders and wasteful further investigation of 'non-renal' stone artefacts. Renal stone analysis is a specialist investigation requiring appropriate analytical and interpretative expertise if the information is to be used to enhance patient care. For those laboratories not able to offer this, for whatever reason, referral is the only defensible approach to service provision. The methods currently employed in many departments have no place in modern clinical biochemistry practice.
Kasidas
G P
GP
Department of Clinical Biochemistry, University College London Hospitals, 60 Whitfield Street, London W1T 4EU, UK. ron.kasidas@uclh.org
Samuell
C T
CT
Weir
T B
TB
D001774:Blood Chemical Analysis; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008855:Microscopy, Electron, Scanning; D008859:Microscopy, Polarization; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D012307:Risk Factors; D013818:Thermogravimetry; D016482:Urinalysis; D014545:Urinary Calculi / Q000737:chemistry* / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D014961:X-Ray Diffraction
D004364:Pharmaceutical Preparations